Last checked at 20 Nov 2019 10:01
Scancell To Receive New European Patent For Moditope Product
Scancell To Receive New European Patent For Moditope Product
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Scancell Holdings Share News (SCLP)
SCLP Share
Price
SCLP Share
News
SCLP Share
Chat32
SCLP Share
Trades13
SCLP
Live RNS
SCLP Share
Charts
SCLP Level 2
Console
SCLP Live
Share Price
SCLP Broker
Ratings
SCLP Directors
Deals
SCLP Financial
Diary
SCLP
Fundamentals
SCLP Short
Positions
SCLP
Media
Scancell Holdings Information
Share Price Information for Scancell Holdings (SCLP)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
9.60
Bid:
9.40
Ask:
9.80
Change:
0.00 (0.00%)
Spread:
0.40 (4.255%)
Open:
9.60
High:
9.60
Low:
9.60
Prev. Close:
9.60
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.23 Oct 2019 10:48
Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive
Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive
Read more5 Sep 2019 16:03
UK Shareholder Meetings Calendar - Next 7 Days
Friday 6 SeptemberMySale Group (re share placing)Berkeley GroupGreene 9 African Oil & 10 11 Design
Read more4 Sep 2019 08:58
Scancell signs collaboration agreement with antibody technology company
(Sharecast News) - Cancer treatment developer Scancell has inked its first collaboration agreement with a "leading" antibody technology company for its new platform technology, AvidiMab.
Read more20 Aug 2019 10:59
Scancell losses deepen as it presses on with development
(Sharecast News) - Novel immunotherapies developer Scancell Holdings reported a deeper operating loss in its final results on Tuesday, to £6.73m compared to £4.91m in the 2018 financial year.
Read more20 Aug 2019 10:59
Scancell Annual Loss Widens Amid Product Pipeline Development
(Alliance News) - Immunotherapy firm Scancell Holdings PLC on Tuesday said its loss widened on higher development costs, while it is making strong progress on advancing its the 12 months to the of
Read more19 Aug 2019 09:33
Scancell to begin SCIB1 UK trial as FDA issues linger in US
(Sharecast News) - Immunotherapy developer Scancell announced the initiation of and further updates to the 'SCIB1' phase 2 trial in patients with metastatic melanoma also receiving the checkpoint inhibitor 'pembrolizumab' (Keytruda) on Monday.
Read more13 Aug 2019 15:58
UK Earnings, Trading Statements Calendar - Next 7 Days
Wednesday 14 August AvastHalf Year ResultsLookersHalf Year BeattyHalf Year Year
Read more1 Jul 2019 14:42
Scancell Progresses Trials In "Busy And Productive" Six Months
(Alliance News) - Scancell Holdings PLC said on Monday it has been a "busy and productive" six months for the company.The company said that active patient recruitment for the two
Read more18 Jun 2019 14:40
Scancell Appoints Vulpes Investment Management Co-Founder To Board
(Alliance News) - Scancell Holdings PLC on Tuesday said it has appointed Vulpes Investment Management Co-Founder & Portfolio Manager Martin Diggle to its board.Diggle joins the cancer a
Read more13 Jun 2019 13:48
Scancell Shares Jump 30% As Vulpes Invests GBP4 Million (ALLISS)
(Alliance News) - Scancell Holdings PLC's shares soared Thursday as it received GBP3.9 million from a new investor.Scancell shares were up 31% in afternoon trade at a price of 7.00 Life
Read more21 May 2019 13:25
N4 Pharma Appoints John Chiplin as Non-Executive Chairman
LONDON (Alliance News) - N4 Pharma PLC on Tuesday said it appointed John Chiplin as non-executive chair of the company with immediate effect.Furthermore, the pharmaceutical firm appointed a
Read more20 May 2019 11:03
Scancell partnership with Cancer Research moves closer to clinic
(Sharecast News) - Immunotherapy developer Scancell Holdings updated the market on its clinical development partnership with Cancer Research UK for the development of the ;ImmunoBody' vaccine, SCIB2, as a potential treatment for patients with solid tumours, including non-small cell lung cancer (NSCLC), on Monday.
Read more20 May 2019 11:02
Scancell Says Cancer Vaccine SCIB2 Will Be Given Using New Formulation
LONDON (Alliance News) - Scancell Holdings PLC said Monday cancer vaccine SCIB2 is to be administered using a new nanoparticle formulation in an early stage trial.Shares in Scancell were up
Read more10 May 2019 10:49
Scancell Creates Advisory Board And Prepares For Drug Trials
LONDON (Alliance News) - Scancell Holdings PLC on Friday said it has established a clinical advisory board and has begun manufacturing and toxicity testing on its tumour drug in immunotherapy were
Read more